Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee

Current Medical Research and Opinion

Volumn 19, Issue 4, 2003, Pages 336-341

  Liang, T H ^a   Hsu, P N ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Anti inflammatory agents, non steroidal; Diclofenac; Etodolac; Osteoarthritis, knee

Indexed keywords

ANTACID AGENT; DICLOFENAC; ETODOLAC; PARACETAMOL;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ABDOMINAL PAIN; AGED; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DOUBLE-BLIND METHOD; ETODOLAC; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS;

EID: 0038681648     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079903125001866     Document Type: Article

References (10)

1. Glaser K, Sung ML, O'Neil K, Belfast M, Hartman D, Carlson R, Kreft A, Kubrak D, Hsiao CL, Weichman B. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 1995;281:107-11
2. Freitas GG. A double-blind comparison of etodolac and piroxicam in the treatment of osteoarthritis. Curr Med Res Opin 1990;12:255-62
3. Grisanti AM, Lopes Vaz AA, Samara AM. Comparison of etodolac and diclofenac in osteoarthritis of the knee. Clin Ther 1992;14:791-800
4. Neustadt DH. Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis. J Rheumatol 1997;Suppl 47:17-22
5. Porzio F. Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee. Rheumatol Int 1993;13:S19-24
6. Paulsen GA, Baigun S, Galvao de Figueiredo J, Gomes de Freitas G. Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee. Curr Med Res Opin 1991;12:401-12
7. Schattenkirchner M. The safety profile of sustained-release etodolac. Rheumatol Int 1993;13:S31-35
8. Khan FM, Williams PI. Double-blind comparison of etodolac SR and diclofenac SR in the treatment of patients with degenerative joint disease of the knee. Curr Med Res Opin 1992;13:1-12
9. Bacon P. Worldwide experience with etodolac (Lodine®) 300mg b.i.d. in the treatment of osteoarthritis. Rheumatol Int 1993;13:S7-12
10. Lonauer G, Tisscher JR, Lim HG, Bijlsma JWJ. Double-blind comparison of etodolac and diclofenac in patients with rheumatoid arthritis. Curr Med Res Opin 1993;13:70-7